top of page

Recent Posts

BDR Pharma launches new drug for Philadelphia chromosome-positive leukemia

Jul 7, 2023

1 min read

BDR Pharmaceuticals on Wednesday announced the launch of Nilotinib for a rare subtype of the most common childhood cancer, acute lymphoblastic leukemia.

Read more: https://www.financialexpress.com/healthcare/pharma-healthcare/bdr-pharma-launches-new-drug-for-philadelphia-chromosome-positive-leukemia/3157778/

Trial provides first look at long-term outcomes of childhood immunotherapies

“Lower-Risk” Childhood Cancer May Be More Dangerous Than It Appears

Largest study supports three courses of radiation for children with deadly brain tumor

Unraveling how a deadly childhood cancer spreads could keep it in its place

Unraveling how immune aging influences health outcomes for survivors of childhood blood cancers

Unexpected discovery points to a possible route for childhood brain tumor treatments

Turning Pediatric Cancer Discoveries Into Medicines Requires Better Connections

Removing immune 'brake' improves CAR T-cell therapy for pediatric bone cancer

Cardiometabolic Risk in Childhood Cancer Survivors Treated With Anthracyclines

Hodgkin Lymphoma Survivors Face Higher Long-Term Mortality

Archive

Search By Tags

bottom of page